- •CONTENTS
- •PREFACE
- •Ocular discharge
- •Eyelid margin inflammation
- •Inflammatory mass
- •Noninflammatory mass
- •Eyelid malpositions
- •Conjunctival lesions
- •Vascular tumors
- •References
- •2 MALIGNANT TUMORS
- •Introduction
- •Basal cell carcinoma
- •Basal cell nevus syndrome
- •Squamous cell carcinoma
- •Keratoacanthoma
- •Adenocanthoma
- •Sebaceous gland carcinoma
- •Lymphoma
- •Malignant melanoma
- •Sweat gland carcinoma
- •Merkel cell tumor
- •Rhabdomyosarcoma
- •Metastatic eyelid carcinoma
- •References
- •Pigmented lesions
- •Inflammations
- •Discoid lupus
- •Benign cystic lesions
- •Benign epithelial tumors
- •Precancerous epithelial tumors
- •Adnexal tumors
- •Xanthelasma
- •Amyloidosis
- •Neurofibromatosis (von Recklinghausen’s disease)
- •References
- •Basal cell carcinoma
- •Sebaceous carcinoma
- •Squamous cell carcinoma
- •Premalignant eyelid lesions
- •Merkel cell tumor
- •Metastatic eyelid carcinoma
- •Melanocytic tumors
- •References
- •Biopsy techniques
- •Treatment
- •References
- •Skin
- •Muscles
- •Tarsal plates
- •Orbital septum
- •Orbital fat
- •Conjunctiva
- •Vascular supply
- •Lymphatic drainage
- •Nerves of the eyelids
- •Lacrimal drainage system
- •References
- •General principles
- •Principles of radiosurgery
- •References
- •Small central lid margin defects
- •Small lateral or medial lid margin defects
- •Medium lower lid defects extending to the medial canthal angle
- •Medium defects extending beyond the medial canthal angle
- •References
- •Small upper lid margin defects
- •References
- •General considerations
- •Primary closure
- •Advancement flaps
- •Full-thickness skin grafts
- •References
- •Medial canthal defects
- •Lateral canthal defects
- •References
- •INDEX
126
Index
acral lentiginous melanoma 30 |
basal cell carcinoma, surgical excision |
China 13, 14 |
actinic (solar) keratosis 49, 58, 59 |
(cont) |
chronic lymphocytic leukemia 28 |
adenocanthoma 25 |
spontaneous granulation |
cilia 68 |
adenocarcinoma, mucin-secreting 10 |
following 114 |
loss of 10, 11, 68 |
adenoma |
upper eyelid 76, 98–101, 104 |
cisplatin 18 |
pleomorphic 11 |
ulcerative 14, 15, 55 |
Clark levels 30, 60 |
sebaceous 50 |
basal cell nevus syndrome 20 |
clear cell hidradenoma 50, 51 |
adnexal tumors 50–1 |
basosquamous cell carcinoma 18, 24 |
clear cell myoepithelioma 50, 51 |
advancement flap |
benign lesions |
comedo (blackhead) 46 |
Cutler–Beard procedure 102–6 |
cystic 9–10, 44–6 |
compound nevus 10, 38, 39, 58 |
defect not involving lid margins |
epithelial 47–8 |
congenital oculodermal melanocytosis |
108–12 |
inflammatory 7, 8, 40–3 |
40 |
double 117–18 |
pigmented 10, 38–40 |
congenital sebaceous gland hyperplasia |
horizontal 108 |
surgical removal 63 |
50 |
lateral 80–5, 95–6, 98–9 |
see also individual benign lesions |
conjunctiva |
medial canthal defects 117–18 |
benign mixed tumor 11 |
anatomy 69 |
myocutaneous island 84–5, 109–10, |
biopsy techniques 61 |
cysts 12 |
118 |
Black races 11, 12–13, 40 |
dysplasia 23, 49 |
AIDS 25 |
blepharitis 7, 41 |
healing rate 69 |
amyloidosis 52, 53 |
localized to one lid 40 |
malignant melanoma 32, 33 |
anaplastic carcinoma 8 |
seborrheic 40 |
papilloma 12 |
anatomy 65–71 |
staphylococcal 40 |
squamous cell carcinoma 12, 13, |
Anatomy of the Orbit (Beard and |
treatment 40 |
22–3 |
Quickert) 65 |
blood supply 69–70 |
vascular tumors 12 |
anesthesia 77 |
blue nevus 40, 41 |
conjunctivodacryocystorhinostomy |
apocrine sweat gland tumors 32, 50 |
bolster 76, 77, 116 |
(CDCR) 79, 80 |
arteries 69–70 |
Bowen’s disease 20, 58, 59 |
contact lenses, hard 9 |
Asia 13, 14, 26 |
Breslow thickness 30, 60 |
cryotherapy 32, 63 |
|
bridge flap, incision 89, 96, 103 |
basal cell carcinoma 18 |
basal cell carcinoma 11, 14–18 |
Brooke’s tumor 50 |
principles 63 |
age at presentation 14 |
bupivicaine hydrochloride 77 |
squamous cell carcinoma 25 |
association with squamous cell |
café-au-lait spots 52 |
cutaneous horn 43, 49 |
carcinoma 24 |
Cutler–Beard procedure 33, 102–6 |
|
clear cell 16 |
calcifying epithelioma of Malherbe |
cylindroma 50 |
clinical presentations 7, 10, 12 |
50 |
cysts 9–10, 44–6 |
cure rates 14, 62 |
canaliculus |
conjunctival 12 |
destructive 18, 19 |
anatomy 68, 71 |
dermoid 9, 46 |
diagnosis 7, 16, 18 |
marsupialization 80 |
epidermal inclusion 9–10, 44, 45 |
epidemiology 13, 14 |
reconstruction 80, 92–3 |
epidermoid 46 |
etiological factors 14 |
canthotomy 80–1 |
follicular 45 |
histopathology 50, 55 |
capillary hemangioma 12, 13 |
sebaceous 44 |
marginal extension 16 |
capsulopalpebral fascia 66, 67 |
sudiferous 44 |
morpheaform 16, 17, 55 |
carbon-dioxide laser 52 |
|
multicentric 14, 55 |
caruncle 69 |
dacroadenitis 10 |
nodular 7, 14, 15, 16, 55 |
cavernous hemangioma 12 |
dacryocystitis 9 |
non-surgical treatment 18 |
chalazion 8, 42, 43 |
dermal nevus see intradermal nevus |
pigmented 11, 16, 55 |
non-healing 26, 27 |
dermis 65 |
site 14, 15 |
pathological evaluation 42 |
dermoid cyst |
surgical excision 18, 62–3 |
rupture 8 |
presentation and diagnosis 9, 46 |
lower eyelid 79, 82–3, 85, 87–8, |
treatment 42 |
treatment 46 |
91, 94–5 |
cheek rotation flap 110–12, 120–1 |
discharge, ocular 7 |
medial canthus 77 |
chemotherapy 18 |
discoid lupus erythematosus 43 |
Index 127
double advancement flap 117–18 doxorubicin 18
eccrine hidrocystoma 50, 51 eccrine spiradenoma 50, 51 eccrine sweat gland tumors 32, 50,
51 ectropion
following surgery 107, 110, 115 misdiagnosis 12
Ellman Needles Empire 73,74,75
A-8 electrode 74, 75, 90 A-10 electrode 62, 74
Ellman Surgitron Dual Frequency 62, 72, 73
embryonal rhabdomyosarcoma 34 ephelis (freckle) 38
epidermal inclusion cysts 9–10, 44, 45 epidermis 65
epidermoid cysts 46 epiphora 79, 113 excisional biopsy 61
eye bank sclera, transplantation 102–3 eye discharge 7
eyelashes 68
loss 10, 11, 68 eyelid
anatomy 65–71 malposition 12 eyelid reconstruction
general principles 72
see also lower eyelid reconstruction; upper eyelid reconstruction
facial artery 70 facial nerve 70 fat, orbital 68–9
fibroma molluscum 52 flaps 74
cheek rotation 110–12, 120–1 defects not involving lid margins 108–12
lateral advancement 80–8, 95, 96, 98–9, 109
midline forehead 120 periosteal 122–5
tarsoconjunctival 86–95, 99–102, 124 ‘V’ to ‘Y’ rotation 118–19
follicular cyst 45
follicular keratosis, inverted 48 fornix, superior, suspensory ligament
67, 90
freckles (ephelis) 38
frozen section technique 62–3
granulation, spontaneous 113–15
hair follicle tumors 50 hemangioma
capillary 12, 13 cavernous 12
hematoporphyran derivative (HpD) 20 hidrocystoma 50, 51
hordeolum (stye) 8, 41
Hughes procedure 13
modification see modified Hughes procedure
human papilloma virus 25 Hutchinson’s melanotic freckle (lentigo
maligna melanoma) 30, 38
impetigo 42 incisional biopsy 61
inclusion cysts 9–10, 44, 45 inflammatory lesions 7, 8, 40–3 infraorbital artery 70 infraorbital nerve 70, 71 infratrochlear nerve 70, 71 intradermal (dermal) nevus
clinical presentation 10, 38, 39 histopathology 58, 59
inverted follicular keratosis 48 island flap, myocutaneous 84–5,
109–10, 118
junctional nevus 10, 38, 58
keratoacanthoma 10, 25 Korea 26
lacrimal drainage system anatomy 68, 71
reconstruction 79, 80, 92–3, 113 lacrimal papilla 68
lacrimal sac 68, 70, 71 distension 9 tumor 9
lagophthalmos 110 laser, CO2 52
lateral advancement flap
defect not involving lid margins 109 lower eyelid margin defects 80–8, 95, 96
tarsoconjunctival flap coverage 86, 87–8
upper eyelid margin defects 98–9 lateral canthotomy 80–1
lateral canthus, reconstruction 122–5 lentigo maligna 30, 31, 38, 60 lentigo maligna melanoma 30, 38 leukoplakia 23, 49
levator palpebrae superioris 67 aponeurosis 65, 66, 67, 68
lidocaine hydrochloride 77 liquid nitrogen 63
local anesthesia 77
lower eyelid reconstruction canaliculus 80, 92–3
central and medial defects 80, 96 defects not involving lid margin 107–12
lateral defects 86–9, 95, 124 medial canthal defects 84–5, 120–1
medium and large defects 31, 80–3, 89, 90–6
small defects 78–9
lupus erythematosus, discoid 43 lymphangioma 12
lymphatic system 70, 71
lymphoid hyperplasia 28 lymphoma 14, 28–9
Maier, sinus 71
Malherbe, calcifying epithelioma 50 malignant melanoma 14, 30–1
acral lentiginous 30 conjunctival 32, 33 histopathology 60 nodular 30, 60
risk of metastasis 30, 60 spindle-cell 30
superficial spreading 30, 60 treatment 30
marginal artery 70
medial canthal defects 77, 113–21 advancement and rotation flaps 84–5, 117–21
skin graft 77, 116
spontaneous granulation 113–15 medial canthus
deformity 7 malposition 115 swelling 9
meibomian cell carcinoma 10 meibomian glands 8, 68 meibomianitis 7
melanocytic hyperplasia 30 melanocytic nevus 10, 11, 58, 59 melanoma see malignant melanoma Merkel cell tumor 32
clinical appearance 9, 10, 32, 33 histopathology 58
metastatic eyelid carcinoma 8, 34, 58 milia 44
mitotic figures 56, 57
modified Hughes procedure 7, 31, 80, 86–95
large eyelid defects 89, 95 second stage 89, 96
Mohs surgery 18, 62, 112 molluscum contagiosum 10, 42, 43 mucoepidermoid carcinoma 32 Müller’s muscles 67, 90, 102 muscles, anatomy 66–7
myocutaneous island flap 84–5, 109–10, 118
nasolacrimal duct obstruction 9 necrobiotic xanthogranuloma 52 nerves 70, 71
neurofibromatosis 52, 53 nevus 38–40
amelanotic 10, 11 blue 40, 41
compound 10, 38, 39, 58 intradermal (dermal) 10, 38, 39, 58, 59
junctional 10, 38, 58 lid margin 11
lower lid 11
melanocytic 10, 11, 58, 59 of Ota 40
sebaceous of Jadassohn 50 nitrogen, liquid 63
128 Index
nodular hidradenoma 50, 51 non-inflammatory mass 9–10
oculomotor nerve 70 oil-red-O stain 28
ophthalmic artery, branches 69–70 orbicularis oculi 66, 67
orbital fat 67, 68–9 orbital mass 10, 50, 51 orbital septum 67, 68
Oriental races 12–13, 14, 26, 40 Ota, nevus of 40
palpebral arteries, medial 70 palpebral muscles 67, 90, 102 papilloma 12, 47
conjunctival surface 12 differential diagnosis 10, 47
periosteal flap 122–5 pilomatrixoma 50 pleomorphic adenoma, skin 11 plica semilunaris 69
polymorphic B-cell lymphoma 28 preaponeutoric fat 69
premalignant lesions 30, 31, 49, 58, 59 primary closure
lesion not involving lid margin 107 lower lid defect 78–9
upper lid defect 97 ptosis
basal cell carcinoma 12 lymphoma of the eyelid 28, 29 postoperative 97
punctum 68, 71
pyogenic granuloma 8, 42, 43
race 12–13, 26, 40 radiation dermatosis 58 radiation therapy 63
basal cell carcinoma 18 sebaceous gland carcinoma 28 squamous cell carcinoma 25
radiosurgery 72–4 chalazion 42 flaps 74
principles and equipment 72, 73, 74 skin incisions 74
smoke evacuation 73 soft tissue dissection 74
retroauricular skin graft 74–6
defect not involving lid margins 112 lower lid reconstruction 89, 90, 92–3 medial canthal defect 116 procedures 74–6
tarsoconjunctival flap coverage 89, 90
rhabdomyosarcoma 34 Riolan, muscle of 66 rotation flap
cheek 110–12, 120–1 midline forehead 120 ‘V’ to’Y’ 118–19
‘salmon patch’ 28, 29 sclera, eye bank 102–3 sebaceous adenoma 50
sebaceous cell carcinoma see sebaceous gland carcinoma
sebaceous cyst 44
sebaceous gland carcinoma 13, 14, 26–8, 63
clinical presentation 26–7 diagnosis 28
etiological factors 28 histopathology 56, 57 incidence 26
mortality factors 26, 28 treatment 28, 63, 106
sebaceous gland hyperplasia, congenital 50
sebaceous gland tumors, benign 50 seborrheic keratosis 10, 48
skin 65
skin grafts 74–6
defect not involving lid margins 112 eyelid skin 74
full-thickness 76, 112
lower lid reconstruction 89, 90, 92–3 medial canthal defect 116 procedures 74–5
retroauricular skin 74–5, 76, 89, 90, 92–3, 112
split-thickness 76 skin tags 47
smoke evacuation device 73
solar (actinic) keratosis 49, 58, 59 split-thickness grafts 76 spontaneous granulation 113–15 squamous cell carcinoma 20–5, 49
adenoid 25, 56
association with basal cell carcinoma 24
clinical presentations 10, 22–3 conjunctival 12, 13, 22–3 epidemiology 13, 14, 20 histopathology 56, 57
in situ 20–2 invasive 25
non-surgical treatment 25, 63 risk of metastasis 56
surgical excision 63, 85, 101, 105 squamous papilloma 47
stye (hordeolum) 8, 41 sudoriferous cysts 44 sun exposure 14
superficial temporal artery 70 superior fornix, suspensory ligament
67, 90
supraorbital nerve 70, 71 supratrochlear nerve 70, 71 surgical defects
not involving eyelid margins 107–12 primary closure 78–9, 97, 107
see also defects/reconstruction of part concerned
sweat gland carcinoma 32, 33 sweat gland tumors, benign 50, 51
syringocystadenoma papilliferum 50 syringoma
benign 50, 51 malignant 32
tarsal plates 68 tarsoconjunctival flap
dissection 89, 90 large defects 89, 95
lower lid central defects 80, 88–9, 90–5
lower lid lateral defects 86–7, 124 opening 89, 96
skin coverage 86, 87–8, 89, 90 suturing 89, 90
upper eyelid defect 99–102 tarsus
kinking 107 transposition 86
tearing 79, 113 Tefla pad 102–3
transplantation, eye bank sclera 102–3 trichiasis 7
trichilemmoma 50 trichoepithelioma 9, 50 trichofolliculoma 50 trigeminal nerve 70
ultraviolet light 14
upper eyelid reconstruction 97
defects not involving lid margin 107, 110, 112
large defects 102–6
medium-sized margin defects 98–102 small lid margin defects 97
vascular tumors conjunctiva 12 eyelid 12, 13
venous system 70, 71 verruca (wart) 42, 43 viral diseases 42
Von Recklinghausen’s neurofibromatosis 52, 53
‘V’ to ‘Y’ rotation flap 118–19
wart (verruca) 42, 43
Whitnall, superior transverse ligament 66
wound tension 74, 107, 108
xanthelasma 52, 53
zinc chloride paste 62
